Información de Omnicell Inc, dividendo de Omnicell Inc, actividades de los accionistas y más

Más Datos de Omnicell Inc Compañía

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Información de la empresa

Código de la empresaOMCL

Nombre de la empresaOmnicell Inc

Fecha de salida a bolsaAug 08, 2001

Fundada en2000

Director ejecutivoMr. Randall A. Lipps

Número de empleados3670

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 08

Dirección4220 North Freeway

CiudadFORT WORTH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal76137

Teléfono18774159990

Sitio Webhttps://www.omnicell.com/

Código de la empresaOMCL

Fecha de salida a bolsaAug 08, 2001

Fundada en2000

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Randall A. Lipps

Chairman of the Board, President, Chief Executive Officer

446.16K

+30.52%

Mr. Nnamdi Njoku

Chief Operating Officer, Executive Vice President

90.93K

+69.90%

Mr. Robin Gene Seim

Independent Director

40.52K

+7.17%

Ms. Joanne B. Bauer

Lead Independent Director

37.81K

+8.54%

Mr. Corey J. Manley

Executive Vice President, Chief Legal and Administrative Officer

24.42K

+1.60K%

Mr. Bruce E. Scott

Independent Director

16.11K

+20.03%

Mr. Edward Peter Bousa

Independent Director

11.50K

+28.62%

Ms. Mary Garrett

Independent Director

10.09K

+33.32%

Mr. Kaushik (Bobby) Ghoshal

Independent Director

8.12K

--

Ms. Eileen J. Voynick

Independent Director

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Randall A. Lipps

Chairman of the Board, President, Chief Executive Officer

446.16K

+30.52%

Mr. Nnamdi Njoku

Chief Operating Officer, Executive Vice President

90.93K

+69.90%

Mr. Robin Gene Seim

Independent Director

40.52K

+7.17%

Ms. Joanne B. Bauer

Lead Independent Director

37.81K

+8.54%

Mr. Corey J. Manley

Executive Vice President, Chief Legal and Administrative Officer

24.42K

+1.60K%

Mr. Bruce E. Scott

Independent Director

16.11K

+20.03%

Desglose de ingresos

Divisa: USDHora de actualización: dom., 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Connected devices, software licenses, and other

539.17M

48.48%

SaaS, subscription software, and technology-enabled services

243.52M

21.89%

Technical services

238.21M

21.42%

Consumables

91.34M

8.21%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

1.01B

91.02%

Rest of the World

99.86M

8.98%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Connected devices, software licenses, and other

539.17M

48.48%

SaaS, subscription software, and technology-enabled services

243.52M

21.89%

Technical services

238.21M

21.42%

Consumables

91.34M

8.21%

Accionista

Hora de actualización: jue., 13 de mar

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

BlackRock Institutional Trust Company, N.A.

15.23%

The Vanguard Group, Inc.

11.85%

State Street Global Advisors (US)

4.79%

Dimensional Fund Advisors, L.P.

3.51%

Lazard Asset Management, L.L.C.

3.50%

Other

61.11%

Estadísticas de accionistas

Accionista

Proporción

BlackRock Institutional Trust Company, N.A.

15.23%

The Vanguard Group, Inc.

11.85%

State Street Global Advisors (US)

4.79%

Dimensional Fund Advisors, L.P.

3.51%

Lazard Asset Management, L.L.C.

3.50%

Other

61.11%

Tipo

Accionista

Proporción

Investment Advisor/Hedge Fund

49.29%

Investment Advisor

40.68%

Hedge Fund

6.88%

Research Firm

2.55%

Individual Investor

1.78%

Pension Fund

1.39%

Bank and Trust

0.70%

Family Office

0.12%

Sovereign Wealth Fund

0.08%

Participación institucional

Hora de actualización: mar., 4 de mar

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

687

48.93M

104.46%

-7.17M

2024Q4

716

48.64M

104.03%

-9.20M

2024Q3

742

47.70M

103.68%

-13.09M

2024Q2

766

48.23M

105.00%

-10.57M

2024Q1

786

47.95M

104.43%

-7.71M

2023Q4

812

47.51M

104.50%

-6.33M

2023Q3

817

49.57M

109.64%

-4.16M

2023Q2

820

48.12M

106.76%

-6.53M

2023Q1

823

48.10M

106.74%

-4.33M

2022Q4

834

47.00M

105.28%

-3.78M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

7.14M

15.23%

-5.02K

-0.07%

Dec 31, 2024

The Vanguard Group, Inc.

5.55M

11.85%

+28.57K

+0.52%

Dec 31, 2024

State Street Global Advisors (US)

2.24M

4.79%

-22.72K

-1.00%

Dec 31, 2024

Dimensional Fund Advisors, L.P.

1.64M

3.51%

+394.82K

+31.64%

Dec 31, 2024

Lazard Asset Management, L.L.C.

1.64M

3.5%

+737.54K

+81.56%

Dec 31, 2024

Victory Capital Management Inc.

1.53M

3.26%

+377.88K

+32.90%

Dec 31, 2024

Champlain Investment Partners, LLC

1.47M

3.15%

-73.36K

-4.74%

Dec 31, 2024

Nikko Asset Management Co., Ltd.

1.45M

3.1%

+699.92K

+93.26%

Dec 31, 2024

ArrowMark Colorado Holdings, LLC

1.20M

2.56%

+56.12K

+4.92%

Dec 31, 2024

Macquarie Investment Management

1.11M

2.38%

-3.94K

-0.35%

Dec 31, 2024

ETFs relacionados

Hora de actualización: dom., 6 de abr

Nombre

Proporción

Global X Telemedicine & Digital Health ETF

1.98%

Texas Capital Texas Small Cap Equity Index ETF

1.82%

SPDR S&P Health Care Equipment ETF

1.6%

Fidelity Digital Health ETF

1.38%

ROBO Global Healthcare Technology & Innovation ETF

1.13%

Invesco S&P SmallCap Health Care ETF

1.05%

Federated Hermes MDT Small Cap Core ETF

0.71%

Global X Robotics & Artificial Intelligence ETF

0.67%

Royce Quant Small-Cap Quality Value ETF

0.46%

Invesco NASDAQ Future Gen 200 ETF

0.42%

Global X Telemedicine & Digital Health ETF

Proporción1.98%

Texas Capital Texas Small Cap Equity Index ETF

Proporción1.82%

SPDR S&P Health Care Equipment ETF

Proporción1.6%

Fidelity Digital Health ETF

Proporción1.38%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.13%

Invesco S&P SmallCap Health Care ETF

Proporción1.05%

Federated Hermes MDT Small Cap Core ETF

Proporción0.71%

Global X Robotics & Artificial Intelligence ETF

Proporción0.67%

Royce Quant Small-Cap Quality Value ETF

Proporción0.46%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.42%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Omnicell Inc

30.840USD

Omnicell Inc

30.840

Descripción general

Compañía